Skip to main content
Equibles
GERN logo

GERN · Geron Corp · Metrics

Track GERN — free

Use GERN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GERN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.12 -0.01 (-0.88%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$719.57M
Shares
642.47M
Volume · Oct 23 11.23M Avg daily vol (3M) 9.92M

GERN metrics

72 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.12
Market cap
$719.57M

Price action

20 metrics
Price change (1W)
-4.3%
Price change (30D)
-11.1%
Price change (3M)
-21.1%
Price change (6M)
-25.3%
Price change (YTD)
-15.2%
Price change (1Y)
-8.2%
Trailing year
Price change (5Y)
-22.8%
52-week high
$1.95
52-week low
$1.07
Change from 52-week high
-42.6%
Change from 52-week low
+4.7%
Annualized volatility
63.7%
Annualized volatility (3M)
67.1%
Beta
1.3
RSI (14D)
34.4
Price vs SMA 50
-16.6%
Price vs SMA 200
-21.9%
Avg volume (3M)
9.92M
Relative volume
1.1
Average dollar volume
$13.77M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
642.47M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
25.2×
reciprocal yield 4.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
24.4×
reciprocal yield 4.1%
P / book
3.3
reciprocal yield 30.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2,173.9×
reciprocal yield 0.0%
EV / revenue historical average (5Y)
2,005.5×
reciprocal yield 0.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
-81,832.9%
Trailing 12 months
Net margin
-77,690.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$51.77M
Net income (TTM)
−$67.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.11
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$-0.34
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.35

Growth

11 metrics
Revenue growth YoY
+17.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$29.48M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
-2.2%
Revenue CAGR (5Y)
-26.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-30.9%
Return on assets
-13.0%
Debt / equity
—
Current ratio
6.9
EBITDA (TTM)
−$51.28M
Free cash flow (TTM)
—
Quick ratio
5.2
Interest coverage
-1.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$62.64M
Total assets
$519.01M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$114.38M
Capital expenditures (TTM)
$885,000
R&D (TTM)
$71.61M
SG&A (TTM)
$154.96M
Stock compensation (TTM)
$22.33M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
261
13F filer change QoQ
+5
Institutional ownership
74.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
36.7%
Private-fund adviser ownership
29.8%
Active holders' share change QoQ
-9.9%
Holder tenure
14.3
Price vs estimated holder cost
-29.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.5%

Short interest

3 metrics
Short interest
11.5%
Latest settlement · 7.4 days to cover
Days to cover
7.4d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 886744 CUSIP 374163103 13F (30d) 32 filings 32 filers Visit website Investor relations